The biochemical basis of resistance to toxic analogues of folic acid, such as aminopterin (4-amino-4-deoxyfolic acid) or amethopterin (4-amino-10-methyl-4-deoxyfolic acid), has been the subject of numerous studies in bacteria as well as in higher organisms (4) . Three resistance mechanisms have been identified in the pneumococcus. The first involves dihydrofolate (FH2) reductase (EC 1.5.1.3.) (10) (11) (12) . The second consists of a decreased affinity of the amethopterin transport system for its substrate (15, 16) . The third is linked to a mutation in the structural gene for thymidylate synthetase (6) . Each one of the above mechanisms is under the control of a single gene. A set of pleiotropic mutants has been studied-the mutants of the amiA locus (9, 13) . They are aminopterin resistant, and sensitive to an imbalance in the amounts of the three branched amino acids, L-valine, L-leucine, and L-isoleucine, in the minimal medium defined for Diplococcus pneumoniae (9) . In addition, these mutants are sensitive to L-methionine, DL-ethionine, pfluorophenylalanine, 4-methyltryptophan, and O-methylthreonine (17) . A mutant representative of the amiA locus, amiA 16 , has been investigated for its ability to take up amethopterin. It was found that this uptake system has a reduced affinity for the drug (16) . On the other hand, amiA5, a mutant in which the same locus is affected (13) , has been investigated for its FH, reductase activity (2). These authors concluded that the enzyme is altered in that mutant. According to these two observations, the amiA locus would control two activitiesthe FH2 reductase and the drug uptake system.
To elucidate the biochemical function of this locus, we decided to compare the properties of the FH2 reductase in the wild type and ami-A mutants.
MATERIALS AND METHODS
Strains. Mutants amiA5 and amiA16 were obtained by transformation of the wild-type strain clone 3 (Cls) by nitrous acid-treated deoxyribonucleic acid and plating on complete medium containing 10-5 M aminopterin (13) . ameII mutants exhibit an altered uptake system for amethopterin (16) . They were prepared by genetic transformation of strain Cls with DNA of the appropriate strains obtained from F. M. Sirotnak (12) . These mutants bore lesions in the amiA locus as indicated in Fig. 1 (13) .
Media. In large-scale cultures, we used a peptone medium modified from Sicard (13) . It (17) . accompanies the oxidation of NADPH, to NADP. The assay was carried out in a 1-cm optical path cell maintained at 25 C, in a dual-beam Beckman spectrophotometer, with a reaction mixture containing no crude cell extract as the blank. One unit of enzyme is defined as the decrease in absorption at 340 nm of a 0.01 optical density unit. This corresponds to the reduction of 2.6 nmol of FH2 (5) . Specific activity is equal to the number of enzyme units per milligram of protein.
Initial rates of the reaction were determined by using a graphic recording of the decrease in absorption at 340 nm. In each case, a control without FH, was made. The decrease in optical density at 340 nm measured in this control was subtracted from the value observed in the presence of FH2. No decrease in absorbance occurred during the 5 min when the enzyme or NADPH2 was omitted. A 0.5-ml volume of crude cell extract, corresponding to between 2 and 5 mg of protein, was added to 2 ml of 0.05 M potassium phosphate buffer (pH 7.3) containing ,8-mercaptoethanol (0.0128 M), dihydrofolic acid (0.123 mM), and NADPH2 (0.1 mM). Under these experimental conditions the initial rate of the reaction was constant for at least 2 min.
Preparation of dihydrofolic acid. FH2 was prepared by chemical reduction of folic acid using sodium thiosulfate according to the method of Futterman, modified by Blakley (3) . FH2 precipitated at acidic pH (pH 2). It was collected by cold centrifugation and dissolved in an NaOH solution (10-3 M) containing 0-mercaptoethanol (0.0128 M). Portions (1 ml) can be stored in a freezer at -80 C for at least 2 months without loss of activity. FH2 was identified by its ultraviolet absorption spectrum. The concentration of solutions was measured at 283 nm. At this wavelength, the molecular absorption coefficient for FH2 is 10 x 10' M-I cm-1 (8 Effect of pH on FH2 reductase activity. In 0.05 M phosphate buffer, maximal activity was obtained for pH values between 7 and 7.5 for both wild-type and mutant extracts (Fig. 2) .
Km determination. The variation in the initial rate of reaction was a function of FH2 concentration. On a Lineweaver-Burk plot, it can be seen that both enzymes exhibited Michaelian behavior (Fig. 3) . Values for Km and Vmax were in the same order of magnitude for extracts from both wild-type and mutant strains.
Thermal stability of enzymes. The rate of thermal denaturation of enzyme activity in crude extracts was followed at 42 and 55 C. The results (Table 1) show that enzyme activity was stable for 30 min at 42 and 55 C for wild-type and mutant strains when fresh extracts were used; frozen extracts led to inconsistent results (14; personal observation). At 55 C the rate of inactivation was the same for both strains when the extracts were heated for 1 h (Table 1 ). Cl3   amiAr5   C1l   amiAr5   0   100  100  100  100  1  100  100  100  100   2  100  100  100  100  3  100  100  100  100  5  100  100  60  66  10  100  100  60  50  15  100  100  60  50  20  100  100  50  50  30  100  100  50  50  60  20  23 a Samples of each strain extract were heated and centrifuged at 27,000 x g for 10 min at 0 C. Assays were performed with the supernatants under standard conditions.
Inhibition of enzyme activity by aminopterin. We measured enzymatic activity in the presence of aminopterin with increasing amounts of crude extract by the method of Akermann and Potter (1) . At low protein concentrations, there was no residual activity; it appeared at higher protein concentrations. The curve representing activity as a function of protein concentration became parallel to that for the control without inhibitors (Fig. 4) . This type of curve, obtained with wild-type extract as well as mutant extract, expresses a pseudoirreversible inhibition of the type described by Werkheiser (18) and Sirotnak (11) .
Assuming in the same locus and, since the strains used are isogenic with the wild type except for the amiA mutations, we can consider that these mutations do not affect the properties of the enzyme when measured in crude extracts. These data disagree with those of Benedict and Gray (2) in that their amiA5 mutant, whose origin is the same as the mutant used in our laboratory (13) , had an altered FH2 reductase with a two-to sixfold greater affinity for the substrate than did the enzyme in wild-type extract. Moreover, these authors found that the enzyme from the amiA mutant was considerably more thermolabile than in wild-type extracts. This discrepancy could have resulted from the independent evolution of the strains used by Gray and us, thus producing two different genetic backgrounds resulting in a side effect on amiA mutations, or perhaps from conditions of handling enzymatic extracts such as storage at -20 C. Indeed, we have observed (unpublished results), in agreement with Sirotnak and Hutchison, that freezing induces losses of stability of the enzyme, resulting in less consistent results. Consequently, the characteristic of aminopterin resistance cannot be attributed to an alteration of the FH2 reductase in the amiA5 strain. All the mutations in the amiA locus lead to the same physiological properties (anti-folic resistance, and sensitivity to the imbalance of branched amino acids, L-methionine, DL-ethionine, p-fluorophenyl-alanine, 4-methyltryptophane, O-methylthreonine). Moreover, these mutations are genetically linked (10) (11) (12) (13) (14) (15) (16) (17) ; consequently, we believe that they affect the same gene and that they result in, like amiA5, a wild-type FH2 reductase and, like amiA16 and ameII mutations, an altered uptake system for the drug.
